Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Litvan

Showing results (211-220 of 331) with videos related to

Pageof 34
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2015
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseDaniel Weintraub, Tanya Simuni, Chelsea Caspell-Garcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Daniela Berg, Matthew Stern, et al.
The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.
Acta Neuropathologica|December 16, 2015
The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathyAnn C McKee, Nigel J Cairns, Dennis W Dickson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS research criteria for prodromal Parkinson's diseaseDaniela Berg, Ronald B Postuma, Charles H Adler, et al.
Annals of Clinical and Translational Neurology|April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseDaniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Parkinsonism & Related Disorders|October 3, 2022
Physical activity intensity is associated with cognition and functional connectivity in Parkinson's diseaseErin K Donahue, Siva Venkadesh, Vy Bui, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2007
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task forceBruno Dubois, David Burn, Christopher Goetz, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2019
Risk of Parkinson's disease dementia related to level I MDS PD-MCIJeroen Hoogland, Judith A Boel, Rob M A de Bie, et al.
Pageof 34

Showing results (211-220 of 331) with videos related to

Sort By:
Pageof 34
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2015
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseDaniel Weintraub, Tanya Simuni, Chelsea Caspell-Garcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Daniela Berg, Matthew Stern, et al.
The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.
Acta Neuropathologica|December 16, 2015
The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathyAnn C McKee, Nigel J Cairns, Dennis W Dickson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 17, 2015
MDS research criteria for prodromal Parkinson's diseaseDaniela Berg, Ronald B Postuma, Charles H Adler, et al.
Annals of Clinical and Translational Neurology|April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseDaniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Parkinsonism & Related Disorders|October 3, 2022
Physical activity intensity is associated with cognition and functional connectivity in Parkinson's diseaseErin K Donahue, Siva Venkadesh, Vy Bui, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2007
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task forceBruno Dubois, David Burn, Christopher Goetz, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2019
Risk of Parkinson's disease dementia related to level I MDS PD-MCIJeroen Hoogland, Judith A Boel, Rob M A de Bie, et al.
Pageof 34